Delving into the Latest Updates on Bupleurum nasal spray with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory DiseasesOther Diseases

Active Indication

Acute upper respiratory infectionCommon ColdFever

Inactive Indication-

Originator Organization-

Active Organization

Henan Lixin Pharmaceutical Ltd. By Share Ltd.

Fudan University

Inactive Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

1、对柴胡鼻腔喷雾剂治疗普通感冒引起的发热的临床用药剂量进行探索，为III期临床试验研究设计和给药剂量方案的确定提供依据。 2、以安慰剂作对照，初步评价柴胡鼻腔喷雾剂治疗普通感冒引起的发热的有效性。 3、以安慰剂作对照，初步评价柴胡鼻腔喷雾剂治疗普通感冒引起的发热的安全性。

[Translation]

1. Explore the clinical dosage of Bupleurum nasal spray for the treatment of fever caused by the common cold, and provide a basis for the design of Phase III clinical trials and the determination of the dosage regimen. 2. Using placebo as a control, preliminarily evaluate the effectiveness of Bupleurum nasal spray in the treatment of fever caused by the common cold. 3. Using placebo as a control, preliminarily evaluate the safety of Bupleurum nasal spray in the treatment of fever caused by the common cold.

Start Date22 Apr 2014

Sponsor / Collaborator

Fudan University

[+1]

100 Clinical Results associated with Bupleurum nasal spray

Login to view more data

100 Translational Medicine associated with Bupleurum nasal spray

Login to view more data

100 Patents (Medical) associated with Bupleurum nasal spray

Login to view more data

100 Deals associated with Bupleurum nasal spray

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Acute upper respiratory infection	Phase 3	China	Henan Lixin Pharmaceutical Ltd. By Share Ltd.	23 Aug 2022
Acute upper respiratory infection	Phase 3	China	Fudan University	23 Aug 2022
Common Cold	Phase 3	China	Fudan University	26 Aug 2015
Common Cold	Phase 3	China	Henan Lixin Pharmaceutical Ltd. By Share Ltd.	26 Aug 2015
Fever	Phase 3	China	Henan Lixin Pharmaceutical Ltd. By Share Ltd.	26 Aug 2015
Fever	Phase 3	China	Fudan University	26 Aug 2015

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


WPC2013	Not Applicable	-	58	Xiaoyao Pill	(idtqdvioyi) = cusvzctabq bsxfbrkfsz (mphipjcxla ) View more	Positive	01 Oct 2013
				Bupleurum+Ginkgo	(idtqdvioyi) = ysvsajmptp bsxfbrkfsz (mphipjcxla ) View more